600 studies found for:    Open Studies | "Liver Neoplasms"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Liver Neoplasms"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Fusion Guided Thermal Ablation Combined With External Beam Radiation for Hepatic Neoplasms
Conditions: Liver Neoplasms;   Hepatic Cancer;   Liver Cancer
Interventions: Procedure: Thermal Ablation;   Procedure: Standard External Beam Radiation Therapy
2 Recruiting Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
Conditions: Adult Primary Hepatocellular Carcinoma;   Adult Primary Undifferentiated Hepatocellular Carcinoma;   Advanced Adult Primary Liver Cancer;   Childhood Hepatocellular Carcinoma;   Localized Unresectable Adult Primary Liver Cancer;   Recurrent Adult Primary Liver Cancer;   Recurrent Childhood Liver Cancer;   Stage C Adult Primary Liver Cancer (BCLC);   Stage D Adult Primary Liver Cancer (BCLC);   Stage III Childhood Liver Cancer;   Stage IV Childhood Liver Cancer
Interventions: Drug: sorafenib tosylate;   Other: laboratory biomarker analysis
3 Recruiting PET/CT-Assessment of Liver Tumor Ablation
Conditions: Liver Tumor;   Liver Neoplasms
Interventions: Radiation: N-13 ammonia;   Device: PET/CT scanner
4 Recruiting 3-Tesla MRI Response to TACE in HCC (Liver Cancer)
Conditions: Adult Primary Hepatocellular Carcinoma;   Advanced Adult Primary Liver Cancer;   Localized Resectable Adult Primary Liver Cancer;   Localized Unresectable Adult Primary Liver Cancer;   Stage A Adult Primary Liver Cancer (BCLC);   Stage B Adult Primary Liver Cancer (BCLC)
Interventions: Device: 3 Tesla Magnetic Resonance Imaging;   Drug: Magnevist® (Intravenous (IV) administration of MRI contrast agent)
5 Recruiting Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Liver Cancer
Conditions: Childhood Hepatoblastoma;   Stage I Childhood Liver Cancer;   Stage II Childhood Liver Cancer;   Stage III Childhood Liver Cancer;   Stage IV Childhood Liver Cancer
Interventions: Procedure: therapeutic conventional surgery;   Drug: cisplatin;   Drug: fluorouracil;   Drug: vincristine sulfate;   Drug: doxorubicin hydrochloride;   Drug: irinotecan hydrochloride;   Procedure: liver transplantation;   Other: laboratory biomarker analysis
6 Not yet recruiting TACE With or Without Radiation Therapy in Treating Patients With Stage A-C Liver Cancer
Conditions: Adult Primary Hepatocellular Carcinoma;   Recurrent Adult Primary Liver Cancer;   Stage A Adult Primary Liver Cancer (BCLC);   Stage B Adult Primary Liver Cancer (BCLC);   Stage C Adult Primary Liver Cancer (BCLC)
Interventions: Procedure: transarterial chemoembolization;   Radiation: stereotactic radiosurgery
7 Recruiting Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed By Surgery
Conditions: Adult Primary Cholangiocellular Carcinoma;   Advanced Adult Primary Liver Cancer;   Cholangiocarcinoma of the Extrahepatic Bile Duct;   Cholangiocarcinoma of the Gallbladder;   Localized Unresectable Adult Primary Liver Cancer;   Metastatic Extrahepatic Bile Duct Cancer;   Recurrent Adult Primary Liver Cancer;   Recurrent Childhood Liver Cancer;   Recurrent Extrahepatic Bile Duct Cancer;   Recurrent Gallbladder Cancer;   Stage C Adult Primary Liver Cancer (BCLC);   Stage D Adult Primary Liver Cancer (BCLC);   Stage II Gallbladder Cancer;   Stage III Childhood Liver Cancer;   Stage IIIA Gallbladder Cancer;   Stage IIIB Gallbladder Cancer;   Stage IV Childhood Liver Cancer;   Stage IVA Gallbladder Cancer;   Stage IVB Gallbladder Cancer;   Unresectable Extrahepatic Bile Duct Cancer
Interventions: Drug: trametinib;   Drug: leucovorin calcium;   Drug: fluorouracil;   Drug: capecitabine;   Other: laboratory biomarker analysis
8 Recruiting Dose Escalation Study of OMP-54F28 in Combination With Sorafenib in Patients With Hepatocellular Cancer
Conditions: Hepatocellular Cancer;   Liver Cancer
Intervention: Drug: OMP-54F28 with Sorafenib
9 Recruiting Sorafenib and TRC105 in Hepatocellular Cancer
Conditions: Hepatoma;   Liver Neoplasms;   Adenoma, Liver Cell;   Carcinoma, Hepatocellular
Interventions: Drug: TRC 105;   Drug: Sorafenib
10 Recruiting TheraSphere® for Treatment of Unresectable Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma;   Liver Cancer;   Liver Neoplasm;   Primary Liver Cancer
Intervention: Device: TheraSphere
11 Recruiting Sorafenib Tosylate Following a Liver Transplant in Treating Patients With Liver Cancer
Conditions: Adult Primary Hepatocellular Carcinoma;   Localized Resectable Adult Primary Liver Cancer;   Localized Unresectable Adult Primary Liver Cancer;   Recurrent Adult Primary Liver Cancer
Interventions: Drug: sorafenib tosylate;   Other: placebo;   Other: laboratory biomarker analysis
12 Recruiting Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
Conditions: Adult Primary Hepatocellular Carcinoma;   Advanced Adult Primary Liver Cancer;   Localized Unresectable Adult Primary Liver Cancer;   Recurrent Adult Primary Liver Cancer
Interventions: Drug: doxorubicin hydrochloride;   Drug: sorafenib tosylate;   Other: laboratory biomarker analysis;   Other: pharmacological study
13 Recruiting Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot be Removed by Surgery
Conditions: Adult Primary Hepatocellular Carcinoma;   Advanced Adult Primary Liver Cancer;   Localized Unresectable Adult Primary Liver Cancer;   Recurrent Adult Primary Liver Cancer
Interventions: Radiation: yttrium Y 90 glass microspheres;   Other: laboratory biomarker analysis
14 Recruiting Tivozanib in Treating Patients With Liver Cancer That is Metastatic or Cannot be Removed by Surgery
Conditions: Adult Primary Hepatocellular Carcinoma;   Advanced Adult Primary Liver Cancer;   Localized Unresectable Adult Primary Liver Cancer;   Recurrent Adult Primary Liver Cancer
Interventions: Drug: tivozanib;   Other: pharmacological study;   Other: laboratory biomarker analysis
15 Recruiting Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
Conditions: Adult Primary Hepatocellular Carcinoma;   Advanced Adult Primary Liver Cancer;   Localized Unresectable Adult Primary Liver Cancer;   Recurrent Adult Primary Liver Cancer
Intervention: Radiation: stereotactic body radiation therapy
16 Recruiting PET-CT in Determining the Radioembolization Dose Delivered to Patients With Liver Metastasis, Primary Liver Cancer, or Biliary Cancer
Conditions: Adult Primary Hepatocellular Carcinoma;   Advanced Adult Primary Liver Cancer;   Metastatic Extrahepatic Bile Duct Cancer;   Recurrent Adult Primary Liver Cancer;   Recurrent Extrahepatic Bile Duct Cancer;   Stage D Adult Primary Liver Cancer (BCLC);   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Procedure: PET scan;   Procedure: CT Scan;   Procedure: hepatic artery embolization
17 Recruiting Study of New Software Used During Ablations
Conditions: Liver Cancer;   Neoplasms, Liver;   Hepatic Neoplasms;   Hepatic Cancer
Intervention:
18 Not yet recruiting Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors
Conditions: Adult Primary Hepatocellular Carcinoma;   Advanced Adult Primary Liver Cancer;   Localized Unresectable Adult Primary Liver Cancer;   Recurrent Adult Primary Liver Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Biological: navitoclax;   Drug: sorafenib tosylate;   Other: laboratory biomarker analysis;   Other: pharmacological study
19 Recruiting ADH-1, Gemcitabine Hydrochloride and Cisplatin in Treating Patients With Metastatic Pancreatic or Biliary Tract Cancer That Cannot Be Removed By Surgery
Conditions: Acinar Cell Adenocarcinoma of the Pancreas;   Adenocarcinoma of the Gallbladder;   Adult Primary Cholangiocellular Carcinoma;   Advanced Adult Primary Liver Cancer;   Cholangiocarcinoma of the Gallbladder;   Duct Cell Adenocarcinoma of the Pancreas;   Localized Unresectable Adult Primary Liver Cancer;   Periampullary Adenocarcinoma;   Recurrent Adult Primary Liver Cancer;   Recurrent Gallbladder Cancer;   Recurrent Pancreatic Cancer;   Stage II Gallbladder Cancer;   Stage III Pancreatic Cancer;   Stage IIIA Gallbladder Cancer;   Stage IIIB Gallbladder Cancer;   Stage IV Pancreatic Cancer;   Stage IVA Gallbladder Cancer;   Stage IVB Gallbladder Cancer
Interventions: Drug: ADH-1;   Drug: cisplatin;   Drug: gemcitabine hydrochloride;   Other: laboratory biomarker analysis
20 Recruiting CPI-613 in Treating Patients With Advanced or Metastatic Bile Duct Cancer That Cannot Be Removed By Surgery
Conditions: Adult Primary Cholangiocellular Carcinoma;   Advanced Adult Primary Liver Cancer;   Cholangiocarcinoma of the Extrahepatic Bile Duct;   Cholangiocarcinoma of the Gallbladder;   Localized Unresectable Adult Primary Liver Cancer;   Metastatic Extrahepatic Bile Duct Cancer;   Recurrent Adult Primary Liver Cancer;   Recurrent Extrahepatic Bile Duct Cancer;   Unresectable Extrahepatic Bile Duct Cancer
Intervention: Drug: 6,8-bis(benzylthio)octanoic acid

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years